| Georgetown mall to rival Hamburg
A shopping center nearly as big as Hamburg Pavilion is on the horizon in Scott County. The Shoppes at Equestrian Crossing will have 850,000 square feet of retail and commercial space. It is the second major retail development planned for the fast-growing county. Built on about 225 acres, it will have six big-box anchor stores of more than 75,000 square feet and five or six junior anchor stores of 20,000 to 75,000 square feet. It will include smaller shops, two hotels and a movie theater, said C.J. May, president of the Lexington-based May Commercial Group, which is developing the center with CBL & Associates Properties Inc. CBL & Associates Properties, which is based in Chattanooga, owns Fayette Mall in Lexington and Jefferson Mall in Louisville. May said he has commitments from two big-box stores, but no announcement has been made of which stores will locate there.
Lowe's, Zaxby's in the works as area's growth paces forward
September brings openings for new restaurants and retail stores in Franklin.Do-it-yourself retailer Lowe's will open its doors to the public at 7 a.m. Sept. 18 at the northeast corner of U.S. 31-W and VFW Road, according to spokeswoman Maureen Rich.The grand opening - which represents an average investment for the company of $12 million and creates up to 120 new jobs - will be Sept. 20 and will include a traditional board cutting ceremony, Rich said. Ceremony details have not been finalized.The second-largest home improvement retailer in the world will offer more than 32,000 products overall under one roof in its 94,000 square-foot space in Franklin. Additionally, a 26,500 square-foot garden center will offer a selection of flowers, bushes, trees and garden supplies, tailored to the Kentucky climate and lifestyle, according to Rich.Rich said that over the past decade Lowe's has evolved its stores to accommodate its main customer - women shopping for their family household.
Ad hoc: Epigenomics AG: Ad Hoc (Section 15 WpHG): Epigenomics AG Announces Strategic In Vitro Diagnostics Partnership ...
BERLIN and SEATTLE, Sept. 26, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX.F - News) (ISIN:DE000A0BVT96) has signed today a non-exclusive strategic collaboration and license agreement in molecular diagnostics with Abbott, a global healthcare company. Under the agreement, Abbott and Epigenomics intend to develop an in vitro diagnostic blood test for the early detection of colorectal cancer based on Epigenomics' proprietary DNA methylation biomarker Septin 9. .
|
